Trigyn Tech Q2 Consol. Revenue Up 12% to ₹28,285 Lakh, PAT Surges to ₹1,269 Lakh
Trigyn Technologies reported Q2 FY27 consolidated revenue of ₹28,285.13 Lakhs, up 12% from the previous quarter. Consolidated PAT from continuing operations surged to ₹1,268.93 Lakhs from ₹339.24 Lakhs. Standalone Q2 revenue increased to ₹6,956.41 Lakhs with PAT at ₹480.39 Lakhs, reversing prior quarter losses.
The substantial increase in revenue and profit, especially the turnaround from losses to profits on a standalone basis, is a material development for the company's investors and stakeholders.
The company has shown significant year-on-year and quarter-on-quarter growth in both revenue and profit for both consolidated and standalone results, indicating strong financial performance.
Trigyn Technologies Limited announced its Unaudited Financial Results for the Quarter and Half Year Ended September 30, 2026, with the Board of Directors approving these results on November 04, 2026.
On a Consolidated basis for the quarter ended September 30, 2026, the company reported a revenue of ₹28,285.13 Lakhs, an increase from ₹25,275.74 Lakhs in the previous quarter ended June 30, 2026. Profit After Tax from continuing operations for the quarter significantly rose to ₹1,268.93 Lakhs, compared to ₹339.24 Lakhs in the prior quarter.
For the half year ended September 30, 2026, Consolidated revenue stood at ₹53,560.86 Lakhs, up from ₹46,645.12 Lakhs in the corresponding period of the previous year. Consolidated Profit After Tax from continuing operations for the half year was ₹1,608.16 Lakhs, a substantial jump from ₹94.58 Lakhs in the same period last year.
On a Standalone basis for the quarter ended September 30, 2026, revenue grew to ₹6,956.41 Lakhs from ₹3,799.38 Lakhs in the previous quarter. Profit After Tax for the standalone quarter was ₹480.39 Lakhs, a notable improvement from a loss of ₹(247.98) Lakhs in the prior quarter.
For the standalone half year ended September 30, 2026, revenue was ₹10,755.79 Lakhs, compared to ₹7,883.22 Lakhs in the corresponding half year ended September 30, 2025. Standalone Profit After Tax for the half year was ₹232.41 Lakhs, a significant turnaround from a loss of ₹(651.02) Lakhs in the previous year's corresponding period.
What to do with a filing like this
Trigyn Technologies Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Trigyn Technologies Limited. Read the original for the full detail.